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In a previous microarray study, we identiﬁed a subset of micro RNAS (miRNAs), which
expression was distinctly higher in atretic than healthy follicles of cattle. In the present
study, we investigated the involvement of those miRNAs in granulosa and theca cells during
atresia. Reverse Transcription-quantitative Polymerase Chain Reaction (RT-qPCR) conﬁrmed
that miR-21-5p/-3p, miR-150, miR-409a, miR-142-5p, miR-378, miR-222, miR-155, and miR-
199a-5p were expressed at higher levels in atretic than healthy follicles (9–17 mm, classiﬁed
based on steroidogenic capacity). All miRNAs except miR-21-3p and miR-378 were
expressed at higher levels in theca than granulosa cells. The expression of 13 predicted
miRNA targets was determined in follicular cells by RT-qPCR, revealing downregulation of
HIF1A, ETS1, JAG1, VEGFA, and MSH2 in either or both cell types during atresia. Based on
increases in miRNA levels simultaneous with decreases in target levels in follicular cells,
several predicted miRNA target interactions were conﬁrmed that are putatively involved in
follicular atresia, namely miR-199a-5p/miR-155-HIF1A in granulosa cells, miR-155/miR-222-
ETS1 in theca cells, miR-199a-5p-JAG1 in theca cells, miR-199a-5p/miR-150/miR-378-VEGFA
in granulosa and theca cells, and miR-155-MSH2 in theca cells. These results offer novel
insight on the involvement of miRNAs in follicle development by identifying a miRNA target
network that is putatively involved in follicle atresia.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC
BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
The overwhelming majority of follicles recruited from
the primordial pool during a female’s reproductive life
will undergo atresia before they can reach the ovulatory
stage. Atresia is an active process involving not only cell
death but also resorption of follicular tissue and its
replacement by stromal and new follicular tissue; these
processes involve inﬁltration by immune and other cells,
very much resembling wound healing [1]. Among
several key regulators of wound healing and tissue
remodeling processes across body tissues are microRNAs
(miRNAs) [2].; fax: þ44 (0)131 651
F.X. Donadeu).
r Inc. This is an open access arThe involvement of miRNAs in different aspects of follicle
development has been demonstrated in numerous studies
[3,4]. Much of the existing evidence has been obtained using
follicular cell cultures, mostly granulosa cells. Often reported
effects ofmiRNAs include either the promotion or suppression
of granulosa cell apoptosis [5–10]. Yet, inmanycases, the siteof
expression, if any, of these miRNAs within follicles (ie, gran-
ulosa and theca compartments) or whether their expression
actually changes during follicle atresia, supporting their phys-
iological role, has not been clariﬁed. Moreover, although the
posttranscriptional effects of miRNAs in tissues often involve
targetingofacommongenesimultaneouslybyseveralmiRNAs
and, at the same time, a single miRNA can simultaneously
target multiple genes, previous functional studies in follicles
have often used a one miRNA–one target approach thus
providing limited informationon thewiderbiological effectsof
miRNAs expressed simultaneously acting in coordination.ticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Primer sequences used in messenger RNA analyses.
Gene Sequence (50-30) sense/antisense
18S GCTGGCACCAGACTTG/GGGGAATCAGGGTTCG
CYP19A1 CGCAAAGCCTTAGAGGATGA/ACCATGGTGATGTACTTTCC
E2F2 TCGCTATGACACATCGCTGG/CGTCACGTAGGCCAGTCTCT
ETS1 CACAGTCTCTCCGGCAAAGT/GTGGATGATAGGCCGACTGG
HIF1A CAGAAGAACTTTTGGGCCGC/TCCACCTCTTTTGGCAAGCA
IGF1 AGTGCTGCTTTTGTGATTTCTTGA/
GCACACGAACTGGAGAGCAT
IGF1R AAGCTGAGAAGCAGGCAGAG/CGGAGGTTGGAGATGACAGT
JAG1 GAGTGTGAGTGTTCTCCGGG/TTGGCCTCGCATTCATTTGC
LHCGR GGACTCTAGCCCGTAGG/ACACATAACCACCATACCAAG
MSH2 TGGGCAGAAGTGTCCATTGT/CCCACGCTAATCCAAACCCA
MYD88 AAGTTGTGCGTGTCTG/GGAAATCACATTCCTTGCT
PAPPA TTGCTGCGCTTCTACAGTGA/GCACAGTCACCCTGTAGGTC
RECK GTGCTTCCTTCTCTTGTCTGGA/GGCTTGACAGTATTCTCGGC
SIRT1 GCTTACAGGGCCTATCCAGG/TATGGACCTATCCGAGGTCTTG
TIMP3 GGATTCACCAAGATGCCCCA/GAGCTGGTCCCACCTCTCTA
VEGFA TGTAATGACGAAAGTCTGGAG/TCACCGCCTCGGCTTGTCACA
F.X. Donadeu et al. / Domestic Animal Endocrinology 58 (2017) 76–83 77In a previous study, we used microarray to proﬁle
miRNA expression across a wide range of antral follicle
development stages in cattle [11], a species which follicular
physiology closely resembles the human, particularly when
compared with rodents; by comparing miRNA proﬁles be-
tween steroidogenic-active and steroidogenic-inactive fol-
licles, we identiﬁed a subset of miRNAs that are putatively
involved in the growth of healthy dominant follicles. In the
present study, we focused our attention on those miRNAs
identiﬁed as upregulated during follicle atresia in our
previous study. Speciﬁcally, we established and compared
the expression of miRNAs and their putative targets within
the follicular granulosa and theca compartments to gain
insight into their involvement in follicle atresia.
2. Materials and methods
2.1. Collection and processing of bovine tissues
Follicles from ovaries of cycling beef cattle obtained at
an abattoir were collected as part of a separate study [11].
Individual follicles 9–17 mm in diameter were dissected
out, and the follicular ﬂuid aspirated and centrifuged at
800 g for 10 min. The resulting supernatant was stored at
80C until further analyses, and the cell pellet was com-
bined with the follicular wall free of surrounding stroma
and snap-frozen in liquid nitrogen until RNA extraction.
Alternatively, after hemidissection, follicles were gently
scraped with blunt-ended forceps to collect granulosa and
theca wall compartments. Theca walls were washed
repeatedly to remove any residual granulosa cells. Theca
and granulosa cells from each individual follicle were then
separately snapped frozen in liquid nitrogen.
Intrafollicular concentrations of estradiol and proges-
terone were measured using competitive double antibody
radioimmunoassay kits (Siemens Healthcare Diagnostics
Inc) following the manufacturer’s instructions. All assays
were validated in our laboratory by showing parallelism
between serial sample dilutions and the provided assay
standard curve. Sensitivity of the assays was 0.56 ng/mL
and 0.01 ng/mL, and the intra-assay coefﬁcient of variations
were 6% and 4.3% for estradiol and progesterone,
respectively.2.2. RT-qPCR
Total RNA was extracted using the miRNeasy Mini kit
(Qiagen, UK) and reverse-transcribed using the miScript II
RT kit (Qiagen), as described [11]. Messenger RNA levels
were quantiﬁed using the SensiFAST SYBR Lo-ROX Kit
(Bioline Reagents Ltd, UK) and bovine-speciﬁc primers
(Table 1). For miRNA quantiﬁcation, the miScript SYBR
Green PCR kit and miScript Primer Assays (Qiagen) were
used. All PCRs were run on a MX3005P QPCR system
(Stratagene, CA) using a standard curve to calculate copy
numbers from Cq values [11]. Messenger RNA data were
normalized using 18S values within each sample, and
miRNA data were normalized using endogenous RnU6-2.
Mean intra-assay coefﬁcient of variations for miRNA and
mRNA qPCRs were 9.5% and 11.3%, respectively.2.3. Micro RNA target identiﬁcation
Identiﬁcation of putative miRNA targets was done using
miRTarBase release 6.0 and TargetScan release 7.0 to select
targets experimentally validated in human and/or rodents
(by reporter assay, Western blot and/or RT-qPCR, as
detailed in http://mirtarbase.mbc.nctu.edu.tw/) and
computationally predicted targets within the bovine
genome (http://www.targetscan.org), respectively. For
convenience, each identiﬁed miRNA target interaction was
classiﬁed as high-, medium-, or low-conﬁdence based on
whether it was present in bothmiRTarBase and TargetScan,
miRTarBase only or TargetScan only.
2.4. Statistical analyses
Robust regression and outlier removal (ROUT) test was
applied to datasets, and outlier values (P < 0.01) were
excluded from subsequent analyses. Gene expression data
were assessed for normality using the D’Agostino and
Pearson normality test and were log-transformed before
statistical analysis where necessary. Two-way analysis of
variance followed by unpaired t-tests to identify differences
in gene expression between healthy and atretic follicles
within each cell type were used. Signiﬁcance was consid-
ered at P < 0.05, whereas differences with P values <0.1
were considered to approach signiﬁcance. Nomenclature
according to miRBase release 21 is used throughout the
manuscript. All miRNAs referred to are bovine (bta-) except
otherwise speciﬁed.
3. Results
3.1. Micro RNA expression analyses in follicular tissues
In a previous study in cattle [11], microarray analyses
yielded a total of 11 unique bovine sequences, which were
expressed in greater abundance (>1.5-fold) in atretic than
in healthy preovulatory size follicles (Table 2). The status
of the follicles analyzed in that study had been pre-
determined on the basis of steroidogenic capacity and
Table 2
Bovine miRNA sequences which expression was upregulated (>1.5-fold) in atretic relative to healthy folliclesa.
miRNA Microarray RT-qPCR
Fold change Adjusted P valueb Fold change P value
bta-miR-483/hsa-miR-483-3p 3.64 0.001 0.88 0.409
bta-miR-21-3p/hsa-miR-21-3p 3.09 0.002 3.38 0.021
bta-miR-150/hsa-miR-150-5p 2.54 0.001 2.92 0.001
bta-miR-21-5p/hsa-miR-21-5p 2.39 0.001 4.90 0.001
bta-miR-409a/hsa-miR-409a-5p 2.36 0.000 1.85 0.001
bta-miR-744/hsa-miR-744-5p 2.36 0.002 0.73 0.057
bta-miR-142-5p/hsa-miR-142-5p 2.03 0.001 2.81 0.001
bta-miR-378/has-miR-378a-3p 1.91 0.001 1.51 0.017
bta-miR-222/hsa-miR-222-3p 1.84 0.000 1.92 0.001
bta-miR-155/hsa-miR-155-5p 1.66 0.019 5.66 0.001
bta-miR-199a-5p/hsa-miR-199a-5p 1.63 0.004 1.66 0.001
a Microarray analyses were performed in 6 healthy and 5 atretic follicles (12–17 mm in diameter) in a previous study (data adapted from Sontakke et al,
2014). Microarray data were validated by qPCR in the present study using 26 healthy and 15 atretic follicles (9–17 mm in diameter).
b FDR; Benjamini and Hochberg adjustment.
F.X. Donadeu et al. / Domestic Animal Endocrinology 58 (2017) 76–8378LHGCR expression in granulosa cells (Fig. 1). Microarray
results were validated by RT-qPCR in the present study,
conﬁrming the upregulation of 9 miRNAs in atretic folli-
cles (Table 2).
To gain insight on the involvement of these miRNAs
in follicle development, we quantiﬁed their relative
expression in granulosa and theca cell compartments. This
showed that all miRNAs except for miR-21-3p and miR-378
were expressed in greater abundance (between 2-fold and
25-fold) in theca than in granulosa cells (cell type, P< 0.05;
Fig. 2). Moreover, an effect of follicle status (P < 0.05),
owing to overall higher expression levels in atretic follicles,
was detected for all miRNAs except miR-21-5p and miR-
378; for miR-378, an interaction approached signiﬁcance
(P ¼ 0.07), reﬂecting higher expression levels in granulosa
but not theca cells from atretic follicles.3.2. Identiﬁcation and expression analyses of miRNA targets
To identify putative targets of the 9 miRNAs in cattle, we
used miRTarBase, a database containing experimentally
validated targets of human, mouse, and rat miRNAs, andwe
selected 36 genes that were simultaneous targets of 2 of
those miRNAs (Table S1). To increase conﬁdence in our
target selection,we then searched all 36 genes inTargetScan
and selected those, 16 in total, which bovine homologues
were computationally predicted targets of one or more of
the corresponding bovine miRNA sequences (Table S1).estradiol Progesterone
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Fig. 1. Mean ( standard error) concentrations of estradiol, progesterone, and trans
healthy (n ¼ 26) or atretic (n ¼ 15). Differences between group means are indicateFinally, we assessed the validity of these predictions by
analyzing by qPCR the expression in follicular cells of 8 of
the 16 genes identiﬁed (Table 3 and Fig. 3; an additional 2
targets, E2F2 and SIRT1, were also selected but could not be
detected in follicular cells by RT-qPCR). For completeness,
our qPCR analyses also included 1 gene (MYD88), which
interactions with 2 miRNAs were experimentally validated
but not computationally predicted in bovine (Table 3 and
Fig. 3), and 2 genes, IGF1 and PAPPA, which were compu-
tationally predicted bovine targets of 2 miRNAs (miR-222
and miR-378) and 3 miRNAs (miR-142-5p, miR-150, and
miR-378), respectively, but none of which were experi-
mentally validated in any species, ie, they were present in
TargetScan but not in miRTarBase (Table 3 and Fig. 3).
As shown in Figure 3, of the remaining miRNA targets, 8
were enriched (cell type, P < 0.05) in either granulosa cells
(HIF1A, IGF1R, and PAPPA) or theca cells (ETS1, JAG1, MSH2,
IGF1, and TIMP3A), and 5 targets were differentially
expressed according to follicle status, in all cases involving
a reduction in atretic follicle cells, as indicated by a signif-
icant effect of follicle status or a follicle status  cell type
interaction (HIF1A, ETS1, JAG1, VEGFA, and MSH2).3.3. Validation of miRNA target interactions
Comparing expression proﬁles between miRNAs and
mRNAs (Figs. 2 and 3) allowed for the testing, based on a
negative association between the expression of a miRNACYP19A1 LHCGR
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Fig. 2. Relative miRNA levels (mean  standard error; normalized to levels of RnU6-2) in granulosa and theca cells from bovine healthy (n ¼ 9) and atretic (n ¼ 6)
follicles. Differences between group means within each cell type are indicated by an asterisk (P < 0.05). miRNA, micro RNA.
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type, a total of 12 high-conﬁdence miRNA target in-
teractions (ie, obtained from both miRTarBase and
TargetScan; indicated by dark gray in Table 3), 8 medium-
conﬁdence interactions (obtained from miRTarBase but
not present in TargetScan; indicated by light gray in
Table 3), and 5 low-conﬁdence interactions (identiﬁed in
TargetScan but not present in miRTarBase; indicated by an
“X” in Table 3).
Of the 12 predicted high-conﬁdence interactions
analyzed, 5 were conﬁrmed by RT-qPCR, speciﬁcally
involving miR-199a-5p and HIF1A in granulosa cells, miR-
155/miR-222 and ETS1 in theca cells, miR-199a-5p and
JAG1 in theca cells, and miR-199a-5p and VEGFA in both
granulosa and theca cells (miRNAs indicated in bold in
Fig. 3A). For another 3 predicted high-conﬁdence in-
teractions, differences in mean miRNA and target levels did
not reach signiﬁcance (P < 0.1). These involved JAG1 and
miR-21-5p in theca cells, MSH2 and miR-21-5p in theca
cells, and IGF1R and miR-378 in granulosa cells (Fig. 3A,B).Four predicted high-conﬁdence interactions involving
TIMP3 and RECK1were not conﬁrmed as the levels of these
transcripts did not change signiﬁcantly according to follicle
status (Fig. 3B).
Of 8 predicted medium-conﬁdence interactions
analyzed (Table 3), 4 were conﬁrmed involving miR-155
and HIF1A in granulosa cells, miR-150 and VEGFA in both
granulosa and theca cells, miR-378 and VEGFA in granulosa
cells, and miR-155 and MSH2 in theca cells (Fig. 3A). For
another 2 medium-conﬁdence interactions, involving miR-
21-5p and VEGFA in both granulosa and theca cells, and
IGF1R and miR-21-5p in granulosa cells (Fig. 3A,B), differ-
ences in mean miRNA and target levels did not reach sig-
niﬁcance (P < 0.1), whereas the remaining 2 medium-
conﬁdence interactions were not conﬁrmed as the levels
of MYD88 did not change with follicle status (Fig. 3B).
Finally, none of the 5 low-conﬁdence interactions
(Table 3) tested were conﬁrmed as transcript abundance of
IGF1, and PAPPA did not change according to follicle status
(Fig. 3B).
Table 3
Candidate miRNA target interactions that were analyzed by qPCR (see Fig. 3).
miR-142-5p miR-150 miR-155 miR-199a-5p miR-21-5p miR-222 miR-378
ETS1
JAG1
RECK
TIMP3
HIF1A
IGF1R
MSH2
VEGFA
MYD88
IGF1
PAPPA
Abbreviation: miRNA, micro RNA.
High-conﬁdence miRNA target interactions obtained from both miRTarBase and TargetScan (ie, both have been experimentally validated in human, rat and/
or mouse and are computationally predicted in bovine) are shown in dark gray. Medium-conﬁdence interactions obtained frommiRTarBase only are shown
in light gray. Low-conﬁdence interactions obtained from TargetScan only are indicated by an “X”.
F.X. Donadeu et al. / Domestic Animal Endocrinology 58 (2017) 76–83804. Discussion
A limited number of studies in cattle [11,12] and pigs [8]
have reported genome-wide miRNA expression proﬁles
associated with follicle atresia. Five of the 9 miRNAs
conﬁrmed to be upregulated in atretic follicles in the pre-
sent study (miR-21-5p, miR-21-3p, miR-222, miR-155, and
miR-199a-5p) were also found to be increased in subordi-
nate relative to dominant follicles on day 3 of the bovine
estrous cycle using deep-sequencing rather than micro-
array [12]. Another miRNA, miR-378, was previously
shown, together with miR-21-5p, to increase in expression
in subordinate and anovulatory follicles in horses [13,14].
Taken together, these results are consistent with an
involvement of these miRNAs in follicular atresia in the
monovular ovary. Indeed, all 9 miRNAs identiﬁed in atretic
follicles in this study can reportedly regulate cell survival
and/or tissue turnover [15–21]. Speciﬁcally in the ovary,
miR-21 promotes cell survival during luteinization [10],
whereas at the same time it is expressed at very high
abundance in the regressing corpus luteum [22], suggest-
ing a multifaceted, developmental stage–dependent
involvement in follicle and corpus luteum function. A pu-
tative involvement of miR-378 in regulating luteal cell
survival in bovine has been suggested but not proven [23].
However, in the pig, miR-378 targets aromatase and pro-
gesterone receptor in granulosa cells and regulates both
ovarian estradiol production and oocyte maturation
[24–26]. Finally, another of the miRNAs investigated in ourstudy, mir-222, may reportedly regulate steroidogenesis of
granulosa cells [27].
Our miRNA target pair analyses provides novel insight
on the molecular regulation of follicular atresia by identi-
fying speciﬁc miRNA networks putatively involved within
different follicular compartments (summarized in Fig. 4).
To identify high-conﬁdence bovine miRNA targets, we
selected genes that both (1) had already been experimen-
tally validated for 2 or more miRNAs in different cellular
contexts in humans and/or rodents (as bovine-speciﬁc in-
formation is not available) and (2) contained predicted
miRNA target sites in the bovine homolog 30 UTR. In
choosing this approach, we took into consideration that (1)
effective target downregulation often involves multiple
miRNAs simultaneously binding the 30 UTR of a gene and
(2) computational prediction of miRNA targets is relatively
inaccurate in terms of both false targets being identiﬁed
and true targets being missed. A similar proportion of
predicted miRNA target interactions classiﬁed as high
conﬁdence (identiﬁed from both miRTarBase and TargetS-
can) and medium conﬁdence (identiﬁed from miRTarBase
only) were conﬁrmed by qPCR (5 of 12 and 4 of 8, respec-
tively), with another 3 and 2 interactions failing to be
validated because miRNA and/or mRNA expression differ-
ences only approached signiﬁcance (P < 0.1). These results
highlight the notion that a signiﬁcant number of true
miRNA targets are normally missed using computational
prediction approaches and that the fact that a target has
been experimentally validated in other species may
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Fig. 3. Relative mRNA levels (mean  standard error; normalized to levels of 18S) in granulosa and theca cells from bovine healthy (n ¼ 9) and atretic (n ¼ 6)
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F.X. Donadeu et al. / Domestic Animal Endocrinology 58 (2017) 76–83 81provide the strongest rationale for target selection, partic-
ularly considering that many miRNAs are functionally
conserved. It needs to be pointed out that failure to detect
differences in predicted target levels by RT-qPCR (eg,
MYD88 in this study) does never by itself provide conclu-
sive evidence that the gene in question is not an actual
target, as miRNAs may in general have greater effects onprotein than transcript levels. Unfortunately, quantiﬁcation
of protein levels is not always possible in bovine due to the
limited availability of species-speciﬁc antibodies.
Among the genes conﬁrmed as miRNA targets in atretic
follicles was VEGFA, which expression was signiﬁcantly
downregulated in both granulosa and theca cells, puta-
tively through the effects of at least 3 different miRNAs.
Fig. 4. Schematic summary of putative miRNA target interactions in gran-
ulosa and theca cells during follicular atresia identiﬁed in this study. miRNA,
micro RNA.
F.X. Donadeu et al. / Domestic Animal Endocrinology 58 (2017) 76–8382Within the follicle, VEGFA has strong trophic effects not
only in vascular cells but also in steroidogenic cells [28,29].
A key transcriptional activator of VEGFA is HIF1A [30]. This
is a gonadotropin-induced, master regulator of cellular re-
sponses to hypoxia which expression in granulosa cells
mediates survival, steroidogenic, and angiogenic responses
within the follicle [30,31]. HIF1A is reportedly expressed at
higher levels in granulosa than theca within nonatretic
follicles [32]. These observations are consistent with our
ﬁnding of a simultaneous decrease in the expression of
HIF1A and VEGFA during bovine follicle atresia, particularly
in granulosa cells. Our results implicate a network of miR-
NAs, namely, miR-199a-5p, miR-155, miR-150, and miR-
378, in the downregulation of the HIF1A-VEGF effector
system during atresia, with one miRNA, miR-199a-5p,
simultaneously targeting both genes, as reported in other
cell types [33].
Two miRNA targets identiﬁed in theca cells and which,
albeit much less characterized, may also be involved in
angiogenesis, are the transcription factor, ETS1, and the
NOTCH1 ligand, JAG1. ETS1 is a proto-oncogen highly
expressed in immune and vascular cells. In the ovary, it has
been shown to be expressed in theca and granulosa cells
and its expression to dynamically change during the
estrous cycle [34,35]. An involvement of ETS1 in regulating
RGS2 expression during ovulation has been shown [36].
Moreover, its role in promoting angiogenesis or as a pro-
apoptotic factor in different cell types [37] could account
for the changes in expression during follicle atresia. Like-
wise, apart from its reported role in promoting early follicle
development, little information is available on the role of
JAG1 in the ovary. An involvement of JAG1 in follicular
angiogenesis is suggested by its expression in endothelial
and other vascular mural cells in mouse ovaries [38]. The
reason for the opposite trends in JAG1 expression in gran-
ulosa and theca cells of healthy and atretic follicles in our
study is unknown, warranting further study of the func-
tions of this gene in the adult ovary.
MSH2, a gene involved in DNA mismatch repair, was
conﬁrmed as a target of miR-155 in theca cells. This isconsistent with the ﬁnding in cattle that atresia involves
the downregulation of cell cycle and DNA replication genes
in theca cells rather than the downregulation of apoptotic
genes as occurs in granulosa cells [39]. Interestingly, a
study showed that another miRNA, miR-26a, targeted the
cell cycle checkpoint kinase, ATM, in porcine follicular cells
during atresia, leading to increased DNA breaking and
apoptosis, and raising the possibility that miR-155 could
exert a similar effect through targeting MSH2 in bovine
theca cells.
Finally, because of the heterogeneous nature of follicular
tissue, particular theca, it is not possible to determine, from
our data, the speciﬁc cell types involved in the identiﬁed
miRNA target interactions. For example, although most
of the miRNAs analyzed in this study are known not to be
cell-speciﬁc, miR-150 and miR-155 are highly expressed
and primarily regulate hematopoietic and vascular cells.
Nonetheless, paracrine regulation of gene expression by
miRNAs has also been described whereby miRNAs are
produced by one cell type and then secreted to regulate
gene expression of a different cell type within a tissue [40],
adding further complexity to the role of miRNA target in-
teractions during follicular atresia.
In summary, by establishing the expression patterns of
miRNAs and their putative targets in granulosa and theca
cells of healthy and atretic follicles in cattle, we have
identiﬁed a network of miRNAs including miR-199a-5p,
miR-155, miR-222, miR-150, and miR-378, which we pro-
pose are involved in follicle atresia through combined tar-
geting of genes involved in cell survival, proliferation, and
differentiation; namely HIF1A and VEGFA in granulosa cells
and MSH2, ETS1, JAG1, and VEGFA in theca cells. Although
the identiﬁed miRNA target interactions should be
conﬁrmed by gene targeting or othermolecular approaches
in future studies, our results will provide fertile ground for
further hypothesis testing toward a better understanding of
the molecular mechanisms involved in follicle atresia.
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